PAFURAMIDINE

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Details

Stereochemistry	ACHIRAL
Molecular Formula	C20H20N4O3
Molecular Weight	364.3978
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure of PAFURAMIDINE

Structure Search

SMILES

CONC(=N)C1=CC=C(C=C1)C2=CC=C(O2)C3=CC=C(C=C3)C(=N)NOC

InChI

InChIKey=UKOQVLAXCBRRGH-UHFFFAOYSA-N

InChI=1S/C20H20N4O3/c1-25-23-19(21)15-7-3-13(4-8-15)17-11-12-18(27-17)14-5-9-16(10-6-14)20(22)24-26-2/h3-12H,1-2H3,(H2,21,23)(H2,22,24)

HIDE SMILES / InChI

Molecular Formula	C20H20N4O3
Molecular Weight	364.3978
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Approval Year

Substance Class	Chemical Created by `admin` on `Fri Dec 15 16:33:17 UTC 2023` Edited by `admin` on `Fri Dec 15 16:33:17 UTC 2023`
Record UNII	H1VG379J2X
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

PAFURAMIDINE

Official Name

English

BENZENECARBOXIMIDAMIDE, 4,4'-(2,5-FURANDIYL)BIS(N-METHOXY-

Systematic Name

English

4,4'-(FURAN-2,5-DIYL)BIS(N-METHOXYBENZENECARBOXIMIDAMIDE)

Systematic Name

English

pafuramidine [INN]

Common Name

English

Classification Tree Code System Code

NCI_THESAURUS

C271

Created by admin on Fri Dec 15 16:33:17 UTC 2023 , Edited by admin on Fri Dec 15 16:33:17 UTC 2023

Code System Code Type Description

FDA UNII

H1VG379J2X

Created by admin on Fri Dec 15 16:33:17 UTC 2023 , Edited by admin on Fri Dec 15 16:33:17 UTC 2023

PRIMARY

WIKIPEDIA

PAFURAMIDINE

Created by admin on Fri Dec 15 16:33:17 UTC 2023 , Edited by admin on Fri Dec 15 16:33:17 UTC 2023

PRIMARY

SMS_ID

300000036950

Created by admin on Fri Dec 15 16:33:17 UTC 2023 , Edited by admin on Fri Dec 15 16:33:17 UTC 2023

PRIMARY

CAS

186953-56-0

Created by admin on Fri Dec 15 16:33:17 UTC 2023 , Edited by admin on Fri Dec 15 16:33:17 UTC 2023

PRIMARY

RXCUI

718967

Created by admin on Fri Dec 15 16:33:17 UTC 2023 , Edited by admin on Fri Dec 15 16:33:17 UTC 2023

PRIMARY

RxNorm

MESH

C458513

Created by admin on Fri Dec 15 16:33:17 UTC 2023 , Edited by admin on Fri Dec 15 16:33:17 UTC 2023

PRIMARY

INN

8760

Created by admin on Fri Dec 15 16:33:17 UTC 2023 , Edited by admin on Fri Dec 15 16:33:17 UTC 2023

PRIMARY

EPA CompTox

DTXSID10870377

Created by admin on Fri Dec 15 16:33:17 UTC 2023 , Edited by admin on Fri Dec 15 16:33:17 UTC 2023

PRIMARY

NCI_THESAURUS

C81542

Created by admin on Fri Dec 15 16:33:17 UTC 2023 , Edited by admin on Fri Dec 15 16:33:17 UTC 2023

PRIMARY

PUBCHEM

459963

Created by admin on Fri Dec 15 16:33:17 UTC 2023 , Edited by admin on Fri Dec 15 16:33:17 UTC 2023

PRIMARY

DRUG BANK

DB06532

Created by admin on Fri Dec 15 16:33:17 UTC 2023 , Edited by admin on Fri Dec 15 16:33:17 UTC 2023

PRIMARY

ChEMBL

CHEMBL319669

Created by admin on Fri Dec 15 16:33:17 UTC 2023 , Edited by admin on Fri Dec 15 16:33:17 UTC 2023

PRIMARY

Related Record Type Details


					K27F04K3A9

PAFURAMIDINE MALEATE

SALT/SOLVATE -> PARENT

Amount:


					4PBV944KVV

CYTOCHROME P450 4F2

METABOLIC ENZYME -> SUBSTRATE

Interaction Type:

MAJOR

Amount:

Related Record Type Details


					08GH1YF0RA

METABOLITE ACTIVE -> PRODRUG

Amount:


					2CMT5WV6NI

DB-775

METABOLITE -> PARENT

Comments:

IN VITRO

Amount:


					FU17RX266J

4-(5-(4-(AMINOIMINOMETHYL)PHENYL)-2-FURANYL)-N-HYDROXYBENZENECARBOXIMIDAMIDE

METABOLITE -> PARENT

Comments:

IN VITRO

Amount:


					9R3RX2015Z

DB-290

METABOLITE -> PARENT

Comments:

IN VITRO

Amount:


					U1INN7V73Z

4-(5-(4-((METHOXYAMINO)IMINOMETHYL)PHENYL)-2-FURANYL)BENZENECARBOXIMIDAMIDE

METABOLITE -> PARENT

Amount:

Related Record Type Details


					08GH1YF0RA

ACTIVE MOIETY

Amount: